Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer

Primary systemic therapy (PST) for operable breast cancer enables the identification of in vivo biological markers that predict response to treatment. A total of 118 patients with T2–4 N0–1 M0 primary breast cancer received six cycles of anthracycline-based PST. Clinical and radiological response wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Burcombe, R J, Makris, A, Richman, P I, Daley, F M, Noble, S, Pittam, M, Wright, D, Allen, S A, Dove, J, Wilson, G D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361750/
https://www.ncbi.nlm.nih.gov/pubmed/15611798
http://dx.doi.org/10.1038/sj.bjc.6602256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361750/
https://www.ncbi.nlm.nih.gov/pubmed/15611798
http://dx.doi.org/10.1038/sj.bjc.6602256

Ejemplares similares